Malady Kyle 4

What Happened

• Kyle Malady, EVP and Group CEO — VZ Business at Verizon Communications (VZ), was granted 89,087 restricted stock units (RSUs) on April 1, 2026. The RSUs are reported as a derivative award with an acquisition price of $0.00 (no cash paid at grant).

Key Details

• Transaction date: 2026-04-01; Form 4 filed: 2026-04-02 (timely filing).
• Transaction type/code: A (award/grant); reported as derivative.
• Shares/units granted: 89,087 RSUs; reported acquisition price: $0.00; reported dollar value at grant: $0.
• Shares owned after transaction: Not disclosed in the provided filing excerpt.
• Footnote: Each RSU represents the right to receive one share plus accrued dividends on the payment date. Per the RSU agreement, these RSUs vest in three equal annual installments beginning March 1, 2027.
• No sale, cashless exercise, or tax-withholding sale is reported in this filing.

Context

• This is a standard equity compensation award to an executive, not an open-market purchase or sale; such grants are part of pay programs and do not necessarily signal insider buying or selling intent. The RSUs convert to shares only as they vest (starting Mar 1, 2027).